RU99112123A - JEWELRY HAVING A NUCLEUS COATED WITH ANTI-FUN FUNCTION AND POLYMER - Google Patents
JEWELRY HAVING A NUCLEUS COATED WITH ANTI-FUN FUNCTION AND POLYMERInfo
- Publication number
- RU99112123A RU99112123A RU99112123/14A RU99112123A RU99112123A RU 99112123 A RU99112123 A RU 99112123A RU 99112123/14 A RU99112123/14 A RU 99112123/14A RU 99112123 A RU99112123 A RU 99112123A RU 99112123 A RU99112123 A RU 99112123A
- Authority
- RU
- Russia
- Prior art keywords
- dragee
- polymer
- antifungal agent
- water
- protective coating
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title claims 3
- 210000004940 Nucleus Anatomy 0.000 title 1
- 239000008298 dragée Substances 0.000 claims 9
- 239000003429 antifungal agent Substances 0.000 claims 6
- 239000011253 protective coating Substances 0.000 claims 5
- 229920003169 water-soluble polymer Polymers 0.000 claims 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 4
- 239000002552 dosage form Substances 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 229920001688 coating polymer Polymers 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 238000005507 spraying Methods 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- VHVPQPYKVGDNFY-TUJWMRSMSA-N 2-[(2S)-butan-2-yl]-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-TUJWMRSMSA-N 0.000 claims 1
- VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical group COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 claims 1
- HUADITLKOCMHSB-AVQIMAJZSA-N 2-butan-2-yl-4-[4-[4-[4-[[(2S,4R)-2-(2,4-difluorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N(C(C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@H]3O[C@@](CN4N=CN=C4)(OC3)C=3C(=CC(F)=CC=3)F)=CC=2)C=C1 HUADITLKOCMHSB-AVQIMAJZSA-N 0.000 claims 1
- VHVPQPYKVGDNFY-ZPGVKDDISA-N Itraconazole Chemical compound O=C1N(C(C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-ZPGVKDDISA-N 0.000 claims 1
- 229950005137 Saperconazole Drugs 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 239000007903 gelatin capsule Substances 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229940031705 hydroxypropyl methylcellulose 2910 Drugs 0.000 claims 1
- 229960004130 itraconazole Drugs 0.000 claims 1
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97200914 | 1997-03-26 | ||
EP97200914.6 | 1997-03-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU99112123A true RU99112123A (en) | 2001-04-20 |
RU2218153C2 RU2218153C2 (en) | 2003-12-10 |
Family
ID=8228147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99112123/15A RU2218153C2 (en) | 1997-03-26 | 1998-03-18 | Nucleus-bearing drops coated with antifungal agent and polymer |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0969821B1 (en) |
JP (1) | JP3608800B2 (en) |
KR (1) | KR100520936B1 (en) |
CN (1) | CN1206984C (en) |
AP (1) | AP1227A (en) |
AT (1) | ATE241969T1 (en) |
AU (1) | AU734248B2 (en) |
BG (1) | BG64434B1 (en) |
BR (1) | BR9806174A (en) |
CA (1) | CA2269501C (en) |
CY (1) | CY2384B1 (en) |
CZ (1) | CZ295502B6 (en) |
DE (1) | DE69815316T2 (en) |
DK (1) | DK0969821T3 (en) |
EE (1) | EE03904B1 (en) |
ES (1) | ES2201485T3 (en) |
HK (1) | HK1022840A1 (en) |
HU (1) | HU224217B1 (en) |
ID (1) | ID21477A (en) |
IL (1) | IL129575A (en) |
NO (1) | NO325102B1 (en) |
NZ (1) | NZ335364A (en) |
OA (1) | OA11162A (en) |
PL (1) | PL190566B1 (en) |
PT (1) | PT969821E (en) |
RU (1) | RU2218153C2 (en) |
SI (1) | SI0969821T1 (en) |
SK (1) | SK284813B6 (en) |
TR (1) | TR199900990T2 (en) |
UA (1) | UA60318C2 (en) |
WO (1) | WO1998042318A1 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100549095B1 (en) * | 1998-07-17 | 2006-02-06 | 얀센 파마슈티카 엔.브이. | Pellets having a core coated with an antifungal and a polymer |
ES2157731B1 (en) | 1998-07-21 | 2002-05-01 | Liconsa Liberacion Controlada | ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION. |
CN1156461C (en) | 1999-03-24 | 2004-07-07 | R·P·希拉技术股份有限公司 | Improved aqueous solubility pharmaceutical formulations |
KR100432949B1 (en) * | 2000-06-13 | 2004-05-31 | 코오롱제약주식회사 | Itraconazole composition of the powders and granules type, its pharmaceutical preparation and method |
US6663897B2 (en) * | 2001-02-06 | 2003-12-16 | Dsm Ip Assets B.V. | Oral itraconazole formulations and methods of making the same |
IL157171A0 (en) | 2001-02-14 | 2004-02-08 | Tibotec Pharm Ltd | Broadspectrum 2-(substituted-amino) -benzothiazole sulfonamide hiv protease inhibitors |
JP4417010B2 (en) | 2001-04-09 | 2010-02-17 | テイボテク・フアーマシユーチカルズ・リミテツド | Wide range 2- (substituted-amino) -benzoxazolesulfonamide HIV protease inhibitors |
CA2444895C (en) | 2001-05-11 | 2011-02-15 | Tibotec Pharmaceuticals Ltd. | Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
WO2002100407A1 (en) * | 2001-06-12 | 2002-12-19 | Smartrix Technologies Inc. | Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same |
US8071133B2 (en) | 2001-08-20 | 2011-12-06 | Stiefel Laboratories, Inc. | Oral dosage forms of water insoluble drugs and methods of making the same |
PL216539B1 (en) | 2001-12-21 | 2014-04-30 | Tibotec Pharm Ltd | Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
MY142238A (en) | 2002-03-12 | 2010-11-15 | Tibotec Pharm Ltd | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
NZ536496A (en) | 2002-05-17 | 2006-06-30 | Tibotec Pharm Ltd | Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors |
KR100994759B1 (en) | 2002-08-14 | 2010-11-16 | 티보텍 파마슈티컬즈 | Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors |
KR100557680B1 (en) * | 2002-11-23 | 2006-03-07 | 한국유나이티드제약 주식회사 | Pellet preparations and methods for improved solubility of itraconazole |
EP1438960B2 (en) * | 2003-01-14 | 2012-12-19 | Acino Pharma AG | Compostion of itraconazole dispersed in a hydrophilic polymer having enhanced bioavailability |
EP1438961B2 (en) * | 2003-01-14 | 2014-08-20 | Acino Pharma AG | Bioequivalent composition of itraconazole dispersed in a hydrophilic polymer |
JP2007501256A (en) | 2003-08-06 | 2007-01-25 | ムルイェ、ニルマル | Pharmaceutical composition containing water-soluble drug |
SG145742A1 (en) | 2003-09-11 | 2008-09-29 | Tibotec Pharm Ltd | Entry inhibitors of the hiv virus |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
AR048650A1 (en) | 2004-05-04 | 2006-05-10 | Tibotec Pharm Ltd | DERIVATIVES OF (1,10B-DIHIDRO-2- (AMINOCARBONIL-PHENYL) -5H-PIRAZOLO [1,5 C] [1,3] BENZOXAZIN-5-IL) METHANONE PHENYL AS INHIBITORS OF HIV VIRAL REPLICATION |
JP5073480B2 (en) | 2004-05-07 | 2012-11-14 | セコイア、ファーマシューティカルズ、インコーポレイテッド | Antiviral resistance retroviral protease inhibitors |
TW200613307A (en) | 2004-05-17 | 2006-05-01 | Tibotec Pharm Ltd | 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
ATE481403T1 (en) | 2004-05-17 | 2010-10-15 | Tibotec Pharm Ltd | SUBSTITUTED 1-PHENYL-1,5-DIHYDRO-PYRIDOÄ3,2- BÜINDOL-2-ONE DERIVATIVES USABLE AS PHARMACEUTICAL ANTIINFECTIVES |
CN1953983B (en) | 2004-05-17 | 2010-05-26 | 泰博特克药品有限公司 | 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
MX2008012790A (en) | 2006-04-03 | 2008-10-15 | Tibotec Pharm Ltd | Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones. |
ZA200901162B (en) * | 2006-09-04 | 2010-06-30 | Panacea Biotec Ltd | Programmable buoyant delivery technology |
KR100809903B1 (en) * | 2006-09-05 | 2008-03-06 | 주식회사유한양행 | Stabilized clopidogrel-containing particles, processes for preparing the same, and pharmaceutical compositions comprising the same |
CN101283984B (en) * | 2007-04-12 | 2010-05-26 | 永胜药品工业股份有限公司 | Core particle object coated by fungicide and polymer with high biological usage |
JP2008280254A (en) * | 2007-05-08 | 2008-11-20 | Everest Pharm Industrial Co Ltd | Core fine granule used in living body at high rate and prepared by being coated with disinfectant and polymer |
US8313527B2 (en) | 2007-11-05 | 2012-11-20 | Allergan, Inc. | Soft prosthesis shell texturing method |
US8569364B2 (en) | 2007-11-28 | 2013-10-29 | Sequoia Pharmaceuticals, Inc. | 5-substituted benzofurans as inhibitors of cytochrome P450 2D6 |
CA2716348C (en) | 2008-02-21 | 2017-04-04 | Sequoia Pharmaceuticals, Inc. | Diamide inhibitors of cytochrome p450 |
US9050184B2 (en) | 2008-08-13 | 2015-06-09 | Allergan, Inc. | Dual plane breast implant |
US8877822B2 (en) | 2010-09-28 | 2014-11-04 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
US9205577B2 (en) | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
GB2479213B (en) | 2010-04-01 | 2013-07-10 | Theravida Inc | Pharmaceutical formulations for the treatment of overactive bladder |
US11202853B2 (en) | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
AU2011252017B2 (en) * | 2010-05-11 | 2015-07-16 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US8679279B2 (en) | 2010-11-16 | 2014-03-25 | Allergan, Inc. | Methods for creating foam-like texture |
CN102100678B (en) * | 2011-02-18 | 2012-10-17 | 天津力生制药股份有限公司 | Itraconazole sulfate capsules and method for preparing same |
EP2931490A1 (en) | 2012-12-13 | 2015-10-21 | Allergan, Inc. | Device and method for making a variable surface breast implant |
US10092392B2 (en) | 2014-05-16 | 2018-10-09 | Allergan, Inc. | Textured breast implant and methods of making same |
MX2018008694A (en) | 2016-01-20 | 2019-05-15 | Theravida Inc | Methods and compositions for treating hyperhidrosis. |
BR112020020941A2 (en) * | 2018-04-16 | 2021-03-02 | Bristol-Myers Squibb Company | apixaban formulations |
CN114767636B (en) * | 2022-04-11 | 2023-11-07 | 苏州中化药品工业有限公司 | Itraconazole pellets, preparation method and itraconazole pellet capsule |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3346123A1 (en) * | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF |
GB8506792D0 (en) * | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
PH30929A (en) * | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
AU731704B2 (en) * | 1996-06-28 | 2001-04-05 | Schering Corporation | Oral composition comprising a triazole antifungal compound |
-
1998
- 1998-03-18 RU RU99112123/15A patent/RU2218153C2/en active
- 1998-03-18 CA CA002269501A patent/CA2269501C/en not_active Expired - Lifetime
- 1998-03-18 WO PCT/EP1998/001773 patent/WO1998042318A1/en active IP Right Grant
- 1998-03-18 CN CNB988020181A patent/CN1206984C/en not_active Expired - Lifetime
- 1998-03-18 PT PT98919155T patent/PT969821E/en unknown
- 1998-03-18 HU HU0002056A patent/HU224217B1/en active IP Right Grant
- 1998-03-18 JP JP54490198A patent/JP3608800B2/en not_active Expired - Lifetime
- 1998-03-18 SK SK544-99A patent/SK284813B6/en not_active IP Right Cessation
- 1998-03-18 AP APAP/P/1999/001516A patent/AP1227A/en active
- 1998-03-18 UA UA99042468A patent/UA60318C2/en unknown
- 1998-03-18 CZ CZ19991398A patent/CZ295502B6/en not_active IP Right Cessation
- 1998-03-18 DE DE69815316T patent/DE69815316T2/en not_active Expired - Lifetime
- 1998-03-18 AT AT98919155T patent/ATE241969T1/en active
- 1998-03-18 BR BR9806174-7A patent/BR9806174A/en not_active Application Discontinuation
- 1998-03-18 ID IDW990316A patent/ID21477A/en unknown
- 1998-03-18 EE EEP199900453A patent/EE03904B1/en unknown
- 1998-03-18 DK DK98919155T patent/DK0969821T3/en active
- 1998-03-18 AU AU72107/98A patent/AU734248B2/en not_active Expired
- 1998-03-18 IL IL12957598A patent/IL129575A/en not_active IP Right Cessation
- 1998-03-18 ES ES98919155T patent/ES2201485T3/en not_active Expired - Lifetime
- 1998-03-18 EP EP98919155A patent/EP0969821B1/en not_active Expired - Lifetime
- 1998-03-18 SI SI9830489T patent/SI0969821T1/en unknown
- 1998-03-18 PL PL98335542A patent/PL190566B1/en unknown
- 1998-03-18 KR KR10-1999-7003848A patent/KR100520936B1/en not_active IP Right Cessation
- 1998-03-18 TR TR1999/00990T patent/TR199900990T2/en unknown
- 1998-03-18 NZ NZ335364A patent/NZ335364A/en not_active IP Right Cessation
-
1999
- 1999-04-23 BG BG103356A patent/BG64434B1/en unknown
- 1999-04-30 NO NO19992114A patent/NO325102B1/en not_active IP Right Cessation
- 1999-09-24 OA OA9900215A patent/OA11162A/en unknown
-
2000
- 2000-03-29 HK HK00101919A patent/HK1022840A1/en not_active IP Right Cessation
-
2003
- 2003-11-04 CY CY0300079A patent/CY2384B1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU99112123A (en) | JEWELRY HAVING A NUCLEUS COATED WITH ANTI-FUN FUNCTION AND POLYMER | |
RU2218153C2 (en) | Nucleus-bearing drops coated with antifungal agent and polymer | |
RU95108537A (en) | GRANULA, METHOD FOR PRODUCING IT AND PHARMACEUTICAL COMPOSITION | |
SI9300461B (en) | Beads having a core coated with an antifugal and a polymer | |
Khandbahale | Microencapsulation-A novel approach in drug delivery: A review | |
RU2000120913A (en) | GRANULES HAVING A NUCLEUS COATED WITH AN ANTI-FUNGAL DRUG AND POLYMER | |
KR950005864B1 (en) | Sustained-release formulation | |
JP2558396B2 (en) | Controlled release formulation | |
JPH06508779A (en) | Method for manufacturing beadlet-shaped medicinal substances | |
JP2560019B2 (en) | Novel formulations controlling the release of active compounds and methods for their production | |
EP1123700B1 (en) | Timed pulsatile drug delivery systems | |
US5246714A (en) | Drug preparation | |
US4975284A (en) | Controlled release means | |
JPH08506802A (en) | Corrugated drug delivery system | |
NZ237418A (en) | Controlled release of drug from micropellets of 170-750 microns diameter | |
US7022342B2 (en) | Controlled release oral dosage form of beta-adrenergic blocking agents | |
CA2581775A1 (en) | Dihydropyrimidine microcapsule - formulations | |
WO1994028882A1 (en) | Multiparticulate pulsatile drug delivery system | |
WO2001000182A1 (en) | Pharmaceutical dosage forms for controlled release producing at least a timed pulse | |
Garg et al. | Microencapsulation techniques in pharmaceutical formulation | |
WO2004110410A1 (en) | Extended release composition containing tramadol | |
Friend | Polyacrylate resin microcapsules for taste masking of antibiotics | |
Sachan et al. | Controlled drug delivery through microencapsulation | |
JP2005075826A5 (en) | ||
CA1268710A (en) | Drug in bead form and process for preparing same |